How to Get Alprostadil (Caverject/MUSE) in Minnesota

What Alprostadil Is and Why It Is Prescribed

Alprostadil is a synthetic prostaglandin E1 (PGE1) that relaxes corporal smooth muscle and dilates penile arterioles, producing an erection sufficient for intercourse in most men with refractory erectile dysfunction (ED). It does not require sexual stimulation to work, which sets it apart from oral phosphodiesterase-5 (PDE5) inhibitors such as sildenafil and tadalafil. Linet and Ogrinc's landmark 1996 randomized controlled trial (N=296) demonstrated that intracavernosal alprostadil produced a satisfactory erection in 87% of injection events versus 17% with placebo injections (P<0.001). [1]

Two FDA-approved delivery formats exist. Caverject (Pfizer) and Edex (Fresenius Kabi) are intracavernosal injections titrated between 1.25 mcg and 40 mcg per dose. MUSE (Meda Pharmaceuticals) is a transurethral suppository available in 125 mcg, 250 mcg, 500 mcg, and 1 to 000 mcg strengths. Both carry full FDA approval for erectile dysfunction. Full Caverject prescribing information is available on the FDA accessdata portal. [2]

Men who have failed two adequate trials of a PDE5 inhibitor, or who cannot use PDE5 inhibitors because of nitrate co-administration or severe cardiovascular contraindications, are the primary candidates. The American Urological Association's ED guideline recommends second-line therapies including intracavernosal vasoactive drugs when first-line oral therapy fails. [3]

Minnesota's Legal Framework for Alprostadil Prescribing

Minnesota permits alprostadil prescribing through all standard clinical channels, and state telemedicine law explicitly allows controlled-substance-exempt prescriptions to be issued after a valid patient-provider relationship is established electronically. Alprostadil is not a DEA-scheduled controlled substance, which removes the most common barrier to telehealth prescribing.

Minnesota Statute §147.037 governs telemedicine practice and requires that a provider perform a documented clinical evaluation sufficient to establish a diagnosis before prescribing. For alprostadil, that evaluation typically includes a structured sexual-health history, a review of cardiovascular risk, and confirmation that oral therapies were inadequate or contraindicated. The Minnesota Board of Medical Practice publishes telemedicine guidance here. [4]

Nurse practitioners (NPs) and physician assistants (PAs) licensed in Minnesota may prescribe alprostadil within their full-practice-authority scope, provided they hold a valid DEA registration and a collaborative agreement where required by their licensure category. A recent JAMA analysis of prescribing scope across U.S. states confirmed that NP full-practice authority is associated with improved access in both rural and urban counties. [5] Minnesota granted NPs full practice authority, meaning no physician supervision is required for an independently licensed NP.

How to Get a Prescription: Step-by-Step

Getting an alprostadil prescription in Minnesota follows a predictable sequence regardless of whether you use in-person or telehealth care.

Step 1. Request an appointment. Contact a urologist, men's health specialist, or a telehealth platform licensed in Minnesota. Telehealth intake is typically completed online in under 10 minutes.

Step 2. Complete the clinical evaluation. Expect questions about ED duration, prior PDE5 inhibitor use (dose, frequency, response), cardiovascular history, current medications (especially nitrates), and any penile anatomical concerns such as Peyronie's disease. A physical exam may be required for the initial intracavernosal dose titration, though some telehealth platforms accept prior titration records from another provider.

Step 3. Labs and screening. Pre-prescription labs commonly ordered include total testosterone (to rule out hypogonadism as a reversible cause), fasting glucose or HbA1c (diabetes is a major ED contributor), and a lipid panel. The Endocrine Society's 2018 testosterone guideline recommends testosterone measurement in all men presenting with ED and low libido. [6] A morning total testosterone below 300 ng/dL warrants treatment before or alongside alprostadil.

Step 4. Dose selection. For Caverject, the starting dose in men with neurogenic ED is 1.25 mcg; for non-neurogenic ED, the starting dose is 2.5 mcg. Titration occurs in-office or under telehealth supervision until a response adequate for intercourse occurs without prolonged erection. The FDA-approved Caverject label specifies that the first injection must be administered by a healthcare provider. [2]

Step 5. Receive the prescription. Once an appropriate dose is established, a written prescription is transmitted electronically to a retail or compounding pharmacy of your choice.

Telehealth Providers Prescribing Alprostadil in Minnesota

Several national telehealth platforms active in Minnesota prescribe alprostadil. Examples include HealthRX, Hims, Roman, and Maximus Men's Health. State licensing requirements mean the prescribing clinician must hold an active Minnesota medical, NP, or PA license.

The telehealth visit for alprostadil commonly takes 20 to 30 minutes. Video consultation is preferred because it allows the provider to observe potential penile curvature (a contraindication to self-injection in Peyronie's disease) and to assess general cardiovascular presentation. A BMJ review of synchronous telehealth for men's sexual health found that asynchronous questionnaire-only models had lower diagnostic accuracy for complex ED compared with synchronous video visits. [7]

After a telehealth visit, most Minnesota patients receive their prescription electronically within 24 to 48 hours. Compounded alprostadil from a 503A pharmacy can be shipped to any Minnesota address, while branded Caverject must be picked up at a licensed retail pharmacy or shipped through a licensed mail-order pharmacy.

HealthRX Minnesota Alprostadil Access Framework: A HealthRX clinical review of the alprostadil prescribing pathway identifies three decision points that determine average time-to-treatment:

1. Prior PDE5 inhibitor documentation (same-day if records are available; 3 to 5 days if records must be requested).
2. Testosterone result availability (same-day if recent labs are on file; 24 to 72 hours if a new draw is needed).
3. Dose titration setting (adds 1 in-office visit if the patient has never been titrated before).

Men who arrive with recent labs and documented PDE5 inhibitor failure can receive a prescription on the day of the telehealth visit.

Pharmacy Access: Retail, Mail-Order, and 503A Compounding

Branded retail pharmacies. Caverject dual-chamber syringes (10 mcg and 20 mcg) and Edex are stocked at most large-chain pharmacies in the Twin Cities metro, including CVS, Walgreens, and Hy-Vee. Availability thins in Greater Minnesota; calling ahead or requesting a transfer to a mail-order pharmacy is advisable for rural residents.

Mail-order pharmacies. Several PBM-affiliated mail-order pharmacies ship Caverject to Minnesota addresses. A 90-day supply through mail order typically costs 10 to 20% less than 30-day retail fills due to quantity discounts. The FDA's guidance on mail-order pharmacy requirements outlines interstate dispensing standards. [8]

503A compounding pharmacies. Minnesota-licensed 503A pharmacies may compound alprostadil for individual patient prescriptions. Compounded alprostadil is typically prepared as a 10 mcg/mL, 20 mcg/mL, or 40 mcg/mL solution in bacteriostatic water or benzyl alcohol diluent. Compounded versions are not FDA-approved, but they are legal under the Drug Quality and Security Act (DQSA) for patient-specific 503A dispensing. [9] Compounding often lowers per-dose cost substantially compared to branded Caverject, which can exceed $80 per single-dose vial at retail without insurance.

Combination formulations are also available from 503A pharmacies: alprostadil combined with papaverine and phentolamine (Trimix) or with papaverine alone (Bimix). These are off-label combinations but are described in the AUA ED guideline as acceptable second-line options. [3] Trimix can achieve efficacy in men who do not respond adequately to alprostadil alone.

Minnesota Medicaid and Insurance Coverage

Minnesota Medicaid (Medical Assistance) covers alprostadil for refractory erectile dysfunction with prior authorization. The clinical criteria for PA generally require:

• Diagnosis of erectile dysfunction confirmed in the medical record.
• Documentation of at least two trials of an oral PDE5 inhibitor at an adequate dose, each lasting at least four weeks, with inadequate response or a documented contraindication.
• Confirmation that ED is not solely attributable to a reversible cause (hypogonadism, medication side effect) that has not been addressed.

The Minnesota Department of Human Services Preferred Drug List provides updated coverage criteria. [10] Processing time for PA requests is typically 3, 5 business days for standard review or 24 hours for urgent requests.

Commercial insurance coverage for alprostadil varies widely. Employer-sponsored plans frequently exclude medications for erectile dysfunction under the "lifestyle drug" exclusion, though this exclusion may be waived when ED results from a covered condition such as prostate cancer surgery or diabetes. Patients should request a benefit determination letter before filling.

Medicare Part D plans cover alprostadil on some formularies. The CMS Part D formulary search tool allows Minnesota beneficiaries to check their specific plan before the prescription is written. [11]

Dosing, Administration, and Safety

Caverject / Edex (intracavernosal injection). The recommended dose range is 1.25 to 40 mcg per injection, administered by the patient at home after training. The injection is given into the lateral aspect of the proximal third of the penis, avoiding the dorsal surface (to avoid neurovascular bundle injury) and the ventral surface (to avoid the urethra). The NIH MedlinePlus alprostadil injection guide provides patient-facing technique instructions. [12]

Maximum frequency is one injection per day and three injections per week. This limit exists because of the risk of priapism and corporal fibrosis with overuse. A Urology review of long-term alprostadil injection safety (N=683, 18-month follow-up) found a 5.7% rate of prolonged erection (>4 hours) in the titration phase, falling to 1.3% after correct dose adjustment. [13]

MUSE (transurethral suppository). The pellet is inserted into the urethra with a single-use applicator immediately before intercourse. Starting dose is 250 mcg, with titration to 500 mcg or 1 to 000 mcg as needed. The MUSE prescribing information notes that a MUSE Starter Pack should be administered in a clinical setting first to monitor for hypotension. [14] Urethral burning is reported in approximately 30% of men and is the most common reason for discontinuation.

Priapism protocol. Any erection lasting more than 4 hours requires urgent emergency care. The American Urological Association priapism guideline recommends intracavernosal phenylephrine as first-line treatment. [15] Patients picking up alprostadil for the first time should receive written priapism instructions; HealthRX includes these with every prescription confirmation.

Transferring an Existing Prescription to Minnesota

Patients relocating to Minnesota from another state with an existing alprostadil prescription can transfer it to a Minnesota-licensed pharmacy. Retail pharmacies can transfer non-controlled prescriptions from out-of-state pharmacies provided the original prescription has remaining refills and was issued by a licensed prescriber.

If the prescribing provider is not licensed in Minnesota, the transferred prescription can still be filled for the remaining refills, but renewal will require a new evaluation by a Minnesota-licensed provider. Telehealth platforms with multi-state licensed prescribers simplify this process; a new synchronous visit establishes the Minnesota provider relationship and issues a fresh prescription.

The DEA telemedicine interim final rule confirms that non-scheduled prescriptions (which includes alprostadil) remain fully prescribable via telehealth without in-person visit requirements. [16]

Prior Authorization Documentation Checklist

Minnesota Medicaid and most commercial insurers require specific documentation. Submitting a complete file on first submission reduces average PA processing time from 5 days to under 48 hours based on HealthRX internal review data.

Required documents typically include:

• Completed PA request form from the insurer or state agency.
• Clinical notes documenting ED diagnosis with onset date.
• Records of two prior PDE5 inhibitor trials: drug name, dose, duration, and response.
• Most recent testosterone result (within 12 months) if hypogonadism was evaluated.
• ICD-10 code N52.x (male erectile dysfunction, subtype as appropriate).
• Provider attestation that the patient was counseled on injection technique and priapism risk.

The CMS prior authorization guidance document outlines federal standards for PA timeliness that Minnesota Medicaid plans must follow. [17] Commercial plans are subject to Minnesota Statutes §62Q.73, which mandates PA decisions within 72 hours for urgent requests.

Who Can Prescribe Alprostadil in Minnesota

Any Minnesota-licensed prescriber with appropriate training and scope of practice may prescribe alprostadil. This includes:

• Physicians (MD/DO): Urologists and primary-care physicians most commonly prescribe alprostadil. Board-certified urologists are preferred for initial titration, especially when penile anatomy is unclear.
• Nurse Practitioners (NPs): Minnesota NPs have full practice authority under Minnesota Statute §148.235. An independently licensed NP may prescribe alprostadil without a physician cosignature. [18]
• Physician Assistants (PAs): PAs may prescribe within a collaboration agreement with a supervising physician. PA prescribing of alprostadil is routine in urology and men's health practices.
• Telehealth prescribers: Any of the above, provided they hold active Minnesota licensure and conduct a compliant telemedicine evaluation per §147.037. [4]

The AAFP position on NP full practice authority notes ongoing debate about independent prescribing scope, but Minnesota law is settled on independent NP authority. [19]

Expected Timeline from Inquiry to First Dose

A Minnesota patient without prior labs or a prior telehealth relationship can realistically expect:

• Day 0: Complete online intake form, upload prior medication records.
• Day 1: Synchronous telehealth visit (20 to 30 min); lab requisition sent if needed.
• Day 1, 3: Lab results returned (LabCorp and Quest both operate patient service centers across Minnesota).
• Day 2, 4: Prescription transmitted to pharmacy.
• Day 3, 7: Compounded alprostadil shipped and received, or branded Caverject available for same-day pickup at a retail pharmacy.

Patients with recent labs on file and documented PDE5 inhibitor failure may complete steps 1 through 4 within a single business day. The FDA drug availability database shows no current shortage status for alprostadil injection formulations as of mid-2025. [2]